Recent Progress in
BTB Round 02
The University of Adelaide
NS1 DNA Vaccine against Zika (ImplaVax®)
View innovation
A T cell-based vaccine that uses the secretion of NS1 DNA against systemic Zika virus infection
More details
Follow
Syntara (formerly Pharmaxis Ltd)
PXS-4699
View innovation
An amine oxidase inhibitor that protects muscle and reduces inflammation in Duchenne Muscular Dystrophy, a debilitating genetic disorder.
More details
Follow
Envision Sciences
Endosomal biomarkers for cancer detection
View innovation
Aims to diagnose prostate cancer based on the presence of the biomarkers APPL1, SORT1, and SDC1 in subject samples.
More details
Follow
INOVIQ Ltd (previously BARD1 Life Sciences Ltd)
Liquid Biopsy Tests
View innovation
A blood test using SubB2M™ technology in detecting and monitoring breast cancer progression.
More details
Follow
Carsinosa (UniQuest)
Therapy To Treat Difficult-To-Treat Cancers
View innovation
A first-of-its kind oral small molecule drug for the treatment of metastatic prostate cancer, breast cancer, ovarian cancer and colon cancer.
More details
Follow
Florey Institute of Neuroscience and Mental Health
Ataxia Instrumented Measurement (AIM) Systems
View innovation
An objective measurement tool that has the potentital to assess whether new treatment modalities's effect on the ataxia progression of the patient.
More details
Follow
Cincera Therapeutics Pty Ltd
Cincera Drug Candidate
View innovation
A therapeutic that may treat obesity-related inflammatory and fibrotic conditions, including the liver disease, non-alcoholic steatohepatitis (NASH).
More details
Follow
MTPConnect innovation projects by program
BTB
MTPConnect's funded projects
All Innovations in
BTB Round 02
Search
The University of Adelaide
NS1 DNA Vaccine against Zika (ImplaVax®)
View innovation
A T cell-based vaccine that uses the secretion of NS1 DNA against systemic Zika virus infection
More details
Follow
Syntara (formerly Pharmaxis Ltd)
PXS-4699
View innovation
An amine oxidase inhibitor that protects muscle and reduces inflammation in Duchenne Muscular Dystrophy, a debilitating genetic disorder.
More details
Follow
Envision Sciences
Endosomal biomarkers for cancer detection
View innovation
Aims to diagnose prostate cancer based on the presence of the biomarkers APPL1, SORT1, and SDC1 in subject samples.
More details
Follow
INOVIQ Ltd (previously BARD1 Life Sciences Ltd)
Liquid Biopsy Tests
View innovation
A blood test using SubB2M™ technology in detecting and monitoring breast cancer progression.
More details
Follow
Carsinosa (UniQuest)
Therapy To Treat Difficult-To-Treat Cancers
View innovation
A first-of-its kind oral small molecule drug for the treatment of metastatic prostate cancer, breast cancer, ovarian cancer and colon cancer.
More details
Follow
Florey Institute of Neuroscience and Mental Health
Ataxia Instrumented Measurement (AIM) Systems
View innovation
An objective measurement tool that has the potentital to assess whether new treatment modalities's effect on the ataxia progression of the patient.
More details
Follow
Cincera Therapeutics Pty Ltd
Cincera Drug Candidate
View innovation
A therapeutic that may treat obesity-related inflammatory and fibrotic conditions, including the liver disease, non-alcoholic steatohepatitis (NASH).
More details
Follow
Real-time innovation tracking powered by
Health
Horizon